Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study
- PMID: 37929764
- PMCID: PMC10727391
- DOI: 10.1161/JAHA.123.029671
Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study
Abstract
Background Our aim was to investigate the association of coronary artery calcium (CAC) with cognitive function in adults with impaired glucose tolerance or type 2 diabetes. Methods and Results The Diabetes Prevention Program was a randomized controlled trial comparing an intensive lifestyle intervention, metformin, or placebo for prevention of type 2 diabetes among patients with prediabetes. After 3 years, intensive lifestyle intervention and placebo were stopped, the metformin arm was unmasked, and participants continued in the DPPOS (Diabetes Prevention Program Outcomes Study). Approximately 14 years after randomization (Y14), CAC (Agatston score) was assessed with computed tomography, and cognitive performance was assessed with the Spanish English Verbal Learning Test (SEVLT) and Digit Symbol Substitution Test. SEVLT and Digit Symbol Substitution Test were reassessed 5 years later (Y19) along with the Modified Mini-Mental State Exam. We examined cross-sectional and longitudinal associations between CAC and cognition among 1931 participants using linear and logistic regression. In unadjusted analyses, compared with no calcification, CAC score >300 was associated with decreased performance on all cognitive tests at Y14 in both sexes. Additionally, CAC >300 was associated with a greater 5-year decline in SEVLT Immediate Recall in both sexes and SEVLT Delayed Recall in women. After adjustment for demographic, genetic, metabolic, vascular, and behavioral covariates, CAC score >300 remained associated with greater decline in only SEVLT Delayed Recall in women. Conclusions In women with prediabetes or diabetes, CAC >300, compared with no calcification, was independently associated with greater decline in verbal memory. Registration information clinicaltrials.gov. Identifier: NCT00038727.
Keywords: cognitive impairment; coronary artery calcium; diabetes; prediabetes; subclinical atherosclerosis.
Figures


References
-
- Mark DB, Berman DS, Budoff MJ, Carr JJ, Gerber TC, Hecht HS, Hlatky MA, Hodgson JM, Lauer MS, Miller JM, et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010;121:2509–2543. doi: 10.1161/CIR.0b013e3181d4b618 - DOI - PubMed
-
- Vidal JS, Sigurdsson S, Jonsdottir MK, Eiriksdottir G, Thorgeirsson G, Kjartansson O, Garcia ME, van Buchem MA, Harris TB, Gudnason V, et al. Coronary artery calcium, brain function and structure: the AGES‐Reykjavik study. Stroke. 2010;41:891–897. doi: 10.1161/STROKEAHA.110.579581 - DOI - PMC - PubMed
-
- Bos D, Vernooij MW, Elias‐Smale SE, Verhaaren BF, Vrooman HA, Hofman A, Niessen WJ, Witteman JC, van der Lugt A, Ikram MA. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement. 2012;8:S104–S111. doi: 10.1016/j.jalz.2012.01.008 - DOI - PubMed
-
- Fujiyoshi A, Jacobs DR Jr, Fitzpatrick AL, Alonso A, Duprez DA, Sharrett AR, Seeman T, Blaha MJ, Luchsinger JA, Rapp SR. Coronary artery calcium and risk of dementia in MESA (Multi‐Ethnic Study of Atherosclerosis). Circ Cardiovasc Imaging. 2017;10:e005349. doi: 10.1161/CIRCIMAGING.116.005349 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 DK048380/DK/NIDDK NIH HHS/United States
- U01 DK048412/DK/NIDDK NIH HHS/United States
- U01 DK048381/DK/NIDDK NIH HHS/United States
- U01 DK048443/DK/NIDDK NIH HHS/United States
- U01 DK048434/DK/NIDDK NIH HHS/United States
- U01 DK048397/DK/NIDDK NIH HHS/United States
- U01 DK048377/DK/NIDDK NIH HHS/United States
- U01 DK048468/DK/NIDDK NIH HHS/United States
- U01 DK048514/DK/NIDDK NIH HHS/United States
- U01 DK048387/DK/NIDDK NIH HHS/United States
- U01 DK048375/DK/NIDDK NIH HHS/United States
- U01 DK048489/DK/NIDDK NIH HHS/United States
- U01 DK048485/DK/NIDDK NIH HHS/United States
- U01 DK048400/DK/NIDDK NIH HHS/United States
- U01 DK048407/DK/NIDDK NIH HHS/United States
- U01 DK048406/DK/NIDDK NIH HHS/United States
- K24 AG045334/AG/NIA NIH HHS/United States
- U01 DK048339/DK/NIDDK NIH HHS/United States
- U01 DK048349/DK/NIDDK NIH HHS/United States
- U01 DK048411/DK/NIDDK NIH HHS/United States
- P30 DK111022/DK/NIDDK NIH HHS/United States
- U01 DK048437/DK/NIDDK NIH HHS/United States
- U01 DK048413/DK/NIDDK NIH HHS/United States
- U01 DK048404/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical